- Trials with a EudraCT protocol (2)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
2 result(s) found for: Graphite.
Displaying page 1 of 1.
EudraCT Number: 2018-002141-11 | Sponsor Protocol Number: Vedolizumab-3035 | Start Date*: 2018-11-08 | |||||||||||
Sponsor Name:Millennium Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease in Subjects Und... | |||||||||||||
Medical condition: Intestinal acute graft-versus-host disease (aGvHD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) SE (Completed) GB (GB - no longer in EU/EEA) NO (Completed) DE (Completed) AT (Completed) PL (Completed) ES (Completed) PT (Completed) BE (Completed) GR (Completed) IT (Completed) RO (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004833-25 | Sponsor Protocol Number: UNLOCK | Start Date*: 2017-03-29 |
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar) | ||
Full Title: Synchronous effect of anesthetics on fMRI, EEG and clinical responses. Development of a more precise system for monitoring anesthetic effect. | ||
Medical condition: General anaesthesia in healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
